|
Symbol
|
ABWBSQ | ABWUSQ | ABWMSQ | ABWQSQ | ABZLSQ | ACALSQ | ACAZSQ | ACBBSQ | ACBQSQ | ACCESQ | ACECSQ | ACEHSQ | ACEESQ | ACBESQ | ACBSSQ | ACCXSQ | ACCWSQ | ACCRSQ | ACFBSQ | ACFCSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Underlying
|
Partners Group Hldg. AG / Swiss Life Hldg. N / UBS Group AG / Zurich Insurance Group AG | Coca-Cola / McDonald's / Starbucks | Clariant AG / Lonza Group N / Sandoz Group AG | Roche PS / Sonova Hldg. AG / Ypsomed Hldg. AG | Adecco Group AG / Kühne & Nagel Intl. AG / VAT Group | Sandoz Group AG / Straumann Hldg. AG / VAT Group | Logitech International SA / Partners Group Hldg. AG / Swiss RE AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG / Helvetia Baloise Holding AG | Compagnie Financière Richemont SA / Logitech International SA / Lonza Group N / Swatch Group I | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Barry Callebaut AG / Dufry AG / Lindt & Sprüngli AG PS | Givaudan / Lonza Group N / Straumann Hldg. AG / Zurich Insurance Group AG | Julius Baer Group / Lonza Group N / Partners Group Hldg. AG | Companie Financière Richemont SA / Kering / LVMH Moet Hennessy Louis Vuitton SE | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | BASF SE / Bayer AG / Clariant AG / Ems-Chemie Hldg. AG | Georg Fischer AG / Glencore Plc. / OC Oerlikon N / Stadler Rail AG | Bachem Hldg. AG / Roche PS / Straumann Hldg. AG | AXA S.A. / Novartis AG / Roche PS / Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
23.10.2026 | 30.10.2026 | 30.10.2026 | 08.05.2026 | 11.06.2026 | 30.06.2026 | 30.06.2026 | 30.06.2026 | 07.07.2026 | 15.07.2026 | 10.02.2027 | 10.02.2027 | 07.08.2026 | 17.02.2027 | 14.08.2026 | 21.08.2026 | 21.08.2026 | 21.08.2026 | 03.09.2026 | 03.09.2026 |
| Bid | 76.28 | 101.04 | 70.13 | 60.49 | 96.33 | 97.19 | 96.83 | 43.550 | 99.94 | 99.81 | 95.40 | 98.69 | 70.46 | 72.22 | 93.96 | 66.48 | 94.94 | 64.95 | 72.58 | 100.72 |
| Ask | - | 101.85 | - | - | - | - | 97.63 | - | - | 100.61 | - | 99.49 | - | - | 94.76 | - | 95.74 | - | - | 101.53 |